Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$405K Sell
23,325
-1,175
-5% -$18.3K ﹤0.01% 579
2026
Q1
$369K Buy
24,500
+251
+1% +$4.01K ﹤0.01% 578
2025
Q4
$478K Sell
24,249
-2,989
-11% -$47.4K ﹤0.01% 516
2025
Q3
$400K Buy
27,238
+377
+1% +$5.05K ﹤0.01% 554
2025
Q2
$369K Buy
26,861
+5,423
+25% +$73.6K ﹤0.01% 570
2025
Q1
$267K Buy
21,438
+117
+0.5% +$1.47K ﹤0.01% 682
2024
Q4
$284K Sell
21,321
-3,325
-13% -$38.3K ﹤0.01% 668
2024
Q3
$277K Sell
24,646
-9
-0% -$129 ﹤0.01% 690
2024
Q2
$331K Buy
24,655
+13,399
+119% +$140K ﹤0.01% 591
2024
Q1
$123K Buy
+11,256
New +$162K ﹤0.01% 761

Other funds holding RIVN

Greenleaf Trust's RIVN Position: Q2 2026 in Review

Greenleaf Trust reduced its Rivian (RIVN) stake by 4.8% in Q2 2026, selling an estimated $18.3K and leaving 23,325 shares worth $405K. The position accounts for ﹤0.01% of the portfolio, ranked #579.

Greenleaf Trust first reported a position in RIVN in Q1 2024 and has held it in 10 quarters since. The position peaked at $478K in Q4 2025. 819 funds tracked by Wall St. Rank hold RIVN as of Q2 2026.

  • Greenleaf Trust held 23,325 shares of Rivian worth $405K as of Q2 2026.
  • Greenleaf Trust sold 1,175 Rivian shares in Q2 2026, an estimated $18.3K.
  • Rivian made up ﹤0.01% of Greenleaf Trust's portfolio in Q2 2026, its #579 holding.
  • Greenleaf Trust first reported a position in Rivian in Q1 2024 and has held it in 10 quarters since.
  • Greenleaf Trust's Rivian position peaked at $478K in Q4 2025.
  • 819 funds tracked by Wall St. Rank held Rivian as of Q2 2026.

Based on Greenleaf Trust's 13F filing for Q2 2026, filed 21 Jul 2026.